Merve Sahin Newsroom

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...

Massive Bio, a New York-based company with an AI tool that matches cancer patients with clinical trials appropriate to their cancer diagnosis, is planning bolt-on acquisitions following a Series B...

November 17th 2022: Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, launches "I Have Cancer," a social media campaign to raise cancer awareness.  In ...